MANCINELLI, LUCA
 Distribuzione geografica
Continente #
NA - Nord America 246
EU - Europa 172
AS - Asia 96
Continente sconosciuto - Info sul continente non disponibili 1
Totale 515
Nazione #
US - Stati Uniti d'America 246
CN - Cina 60
IE - Irlanda 42
UA - Ucraina 31
SE - Svezia 27
TR - Turchia 25
GB - Regno Unito 20
IT - Italia 20
FR - Francia 13
DE - Germania 10
IN - India 10
FI - Finlandia 8
EU - Europa 1
HR - Croazia 1
KR - Corea 1
Totale 515
Città #
Chandler 55
Jacksonville 47
Dublin 42
Ashburn 20
Southend 18
Nanjing 17
Princeton 16
Beijing 15
Dearborn 13
New York 12
Cambridge 8
Izmir 8
Guangzhou 5
Kunming 5
Washington 5
Norwalk 4
Wilmington 4
Altamura 3
Chieti 3
Hebei 3
Torino 3
Hangzhou 2
Jiaxing 2
Nanchang 2
Ningbo 2
San Mateo 2
Shenyang 2
Taizhou 2
Woodbridge 2
Ann Arbor 1
Boardman 1
Edinburgh 1
Genova 1
Grevenbroich 1
Helsinki 1
Hyderabad 1
Lanzhou 1
Leawood 1
Los Angeles 1
Monmouth Junction 1
Montesilvano 1
Recale 1
Redmond 1
Tianjin 1
Zagreb 1
Zhengzhou 1
Totale 339
Nome #
A lipidomic investigation for the caracterisation of CSF lipid profile in patients with multiple sclerosis 82
Nail loss after teriflunomide treatment: a new potential adverse event 68
Anti-JCV serostatus, index value and clinical features in patients affected by multiple sclerosis. 66
Prevalence of JC virus antibodies in human serum and seroconversion rate with first-generation and second generation ELISA: the novel assay improves specificity andsensitivity to detect anti-JC virus antibodies 63
JCV-Ab serostatus in MS patients treated with Natalizumab 62
Natalizumab-associated PML-IRIS: the Chieti experience. 61
Atypical presentation of Cadasil a diagnostic challenge 61
Treatment discontinuation issues in fingolimod treated patients: the Chieti experience. 59
Totale 522
Categoria #
all - tutte 1.570
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.570


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201915 0 0 0 0 0 0 0 0 0 1 0 14
2019/2020112 32 8 2 0 9 11 12 10 4 7 15 2
2020/202136 7 0 8 0 0 9 0 0 7 0 4 1
2021/202232 0 1 1 4 2 1 3 3 1 0 6 10
2022/2023131 9 19 8 9 18 21 6 13 20 3 4 1
2023/202481 4 3 9 2 9 41 11 1 0 1 0 0
Totale 522